Synchronising experience and data: Combining patient and healthcare provider engagement strategies to optimise business and health outcomes
![Synchronising experience and data blocks](/sites/default/files/styles/x_large/public/2023-11/Combining-patient-and-provider%03-engagement-strategies-1200x675.jpg?itok=3XFwpc20)
For pharmaceutical companies and other healthcare stakeholders, it is imperative that they understand how patient experience and input needs to be captured, contextualised, and applied to the process of medicine innovation, from research through to provider education and communication, including point of care.
They need to be leading efforts to ensure data and information is made accessible to a lay audience and the end user to promote responsible education and decision-making around the use of their innovation to complement and strengthen their efforts to engage the clinical audience they have more traditionally targeted.
The emphasis on patient-centric medicine development, where the patient and caregiver voice is increasingly included, recognised, and valued in shaping research, clinical trials, and treatment innovation, has been shown to improve both patient and business outcomes. The rise of engaged and empowered patients has the potential to accelerate the development of safer, more personalised, and effective therapies and improve the overall quality of healthcare.
The concept is also marking a significant shift in the provider–patient relationship. An empowered patient actively participates in their healthcare decisions, seeks to gain a deeper understanding of their health and treatment options, and demonstrates a greater investment in the management of their condition and health. By leveraging technology, patients have greater access to information, control over their health data, and the ability to connect with healthcare providers and peers through a diversity of channels. This leads to a more engaged and informed patient population, fostering a culture of patient empowerment in healthcare.
• Read the full article in pharmaphorum's Deep Dive digital magazine